Return to content in this issue

Efficacy of Mepolizumab in Patients With Severe Eosinophilic Asthma and Concomitant Severe Chronic Urticaria: An Example of Personalized Medicine?

Antonicelli L¹, Tontini C², Garritani MS¹, Piga MA³, Bilò MB<sup>1,3

1</sup>SOSD Allergologia, Dipartimento di Medicina Interna, Azienda Ospedaliero-Universitaria Ospedali Riuniti, Ancona, Italy
²Lydia Becker Institute for Immunology and Inflammation, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
³Dipartimento di Scienze Cliniche e Molecolari, Universita’ Politecnica delle Marche, Ancona, Italy

J Investig Allergol Clin Immunol 2023; Vol 33(1) : 54-56
doi: 10.18176/jiaci.0770